Minimally Invasive CABG (MIDCAB)

Free consultation

Find out whether your anatomy suits a sternum-sparing bypass

The review costs nothing and commits you to nothing. Send the coronary angiogram images themselves alongside the written report, since which vessels are diseased and where the narrowings sit decides everything, along with a recent echocardiogram, any stress test, and a note of previous chest surgery, lung disease, diabetes and current blood thinners. A cardiac surgeon will tell you whether MIDCAB fits your case or whether another approach serves you better.

What MIDCAB actually is

MIDCAB abbreviates minimally invasive direct coronary artery bypass. The surgeon opens a cut of five to eight centimeters between the ribs on the left side of the chest, takes down the internal mammary artery that runs along the inside of the breastbone, and sews it onto the left anterior descending artery on the front of the beating heart. The breastbone is never divided. The heart-lung machine is never used. A stabilizer device holds a small patch of heart wall still while the join is made, and the rest of the heart carries on pumping throughout. That combination is what makes the operation unusual. Conventional bypass surgery divides the sternum lengthwise and usually stops the heart, and both of those facts drive most of what patients dread about it. The graft itself deserves a sentence of its own. The internal mammary artery sewn to the left anterior descending is the single most durable thing cardiac surgery does, outlasting vein grafts by a wide margin over decades, and a MIDCAB delivers exactly that graft through a small incision.

The family of sternum-sparing operations

Hospitals use several names loosely and patients arrive confused by them, so it helps to separate what they actually describe. All of these avoid dividing the breastbone. They differ in how many arteries get bypassed and in what equipment the theater needs.

This table scrolls sideways on a narrow screen. Swipe or drag to see every column.

Hospitals advertising minimally invasive bypass may mean any of these. Establish which one is being proposed for you, in those words, before anything else is discussed.

One graft, one artery, one group of patients

Standard MIDCAB treats the left anterior descending artery and nothing else. Patients arriving with narrowings in three vessels and a printout about keyhole heart surgery are frequently disappointed to hear this, and the disappointment is better handled at the consultation than after a flight.

Two lists decide it, and neither is a judgment about the patient. Each describes what a small incision on a beating heart can safely reach.

Scroll the table sideways on a narrow screen. Swipe or drag to reach every column.

MIDCAB or a stent for the same artery

Anyone with an isolated narrowing of the left anterior descending faces a genuine choice, and the two options sit further apart in the mind than in the data. A stent takes an hour, needs no general anesthetic and sends most people home the next day. Surgery means an operation, several nights in hospital and weeks of recovery. Most patients assume the gentler route must also be the safer one.

What the pooled analysis found

According to PubMed, a systematic review and meta-analysis pooled twelve studies covering 7710 patients with isolated proximal left anterior descending disease treated either by MIDCAB or by a drug-eluting stent (Raja et al, 2018).

On a narrow screen the table scrolls sideways. Drag or swipe to see the remaining columns.

So the two approaches carry the same risk of the outcomes people fear most, and they part company on durability. The stent is likelier to need revisiting.

What it leaves open

One meta-analysis does not settle the decision by itself. A meta-analysis pools observational studies alongside trials, patients selected for surgery differ from those selected for stenting in ways no statistical adjustment fully removes, and a 65-year-old weighing two comfortable decades against a 40-year-old weighing four will reasonably reach different conclusions. Age, other illnesses, what the recovery would cost you in weeks of your life, and how you feel about the prospect of a further procedure some years from now all belong in that conversation alongside the odds ratios.

When more than one vessel is involved

Two routes exist for keeping the breastbone intact when several arteries need treating, and they have traveled in different directions in the evidence.

Grafting several vessels through the same small opening

PubMed indexes a matched comparison in which 244 patients having minimally invasive multivessel surgery were matched against 244 having conventional sternotomy bypass. Completeness of revascularization came out at 95.5 percent against 96.3 percent, angiography after the operation showed overall graft patency of 96.2 percent in the minimally invasive group, and at five years the rates of major adverse cardiac and cerebrovascular events stood at 19.9 percent against 22.1 percent, with death at 10.6 against 12.9 percent and no significant difference in stroke or repeat revascularization (Gong et al, 2024). Two, three and four or more vessels were bypassed in 53.7, 36.1 and 10.2 percent of those cases respectively.

Multivessel work through a small incision is therefore possible, and in experienced hands it holds up. It demands considerably more of the surgeon than the same operation through a divided sternum, and the volume question below therefore matters more here than anywhere else.

Combining surgery with stents

Hybrid revascularization sounds like the best of both worlds. A MIDCAB places the durable mammary graft on the front artery, and stents deal with the rest, sparing both the sternum and a longer operation.

Sixty patients cannot settle a question of this size, and the difference did not reach statistical significance. The finding is a caution. Treat any presentation of hybrid revascularization as an obviously superior option with corresponding skepticism, and ask which vessels would be stented, when, and who decided.

What keeping the sternum closed buys you

Dividing the breastbone creates a broken bone wired back together, and it behaves like one. Six to twelve weeks of healing, restrictions on lifting and on pushing yourself up out of a chair, a ban on driving while the bone is uniting, and a small but serious risk that the wound becomes infected deep down where the wires sit.

The infection risk, quantified

That last risk is the one worth quantifying. According to PubMed, two European surgical series reported deep sternal wound infection in 5.7 percent of 1122 patients at one center and 2.5 percent of 721 at another, with the difference reflecting how many received both mammary arteries and the risk profiles of the patients treated (Gatti et al, 2020). Deep sternal infection is uncommon and it is also one of the most feared complications in cardiac surgery, since treating it means repeat operations, prolonged antibiotics and sometimes reconstruction with muscle flaps. Diabetes, obesity, chronic lung disease and taking both mammary arteries all raise the risk. MIDCAB removes that risk entirely, because there is no divided bone to infect. It also removes the sternal precautions, which is why driving and ordinary lifting return sooner, and it leaves a scar under the left breast or along a rib line, out of sight in a way a midline scar never is.

For a patient carrying diabetes, a high body weight or chronic lung disease into the operation, none of that is a cosmetic advantage.

The pain nobody warns you about

Marketing for minimally invasive heart surgery implies less pain. The reality is more interesting, and it belongs in the conversation before the operation. Getting to the heart through the ribs means spreading them apart, and the small nerves running under each rib resent that treatment considerably. Early pain after a thoracotomy can exceed early pain after a sternotomy, and it is felt in a place patients do not expect, meaning the side and the back rather than the front of the chest. What changes is the shape of the curve. The height at the start stays much the same.

There is no broken bone knitting for three months, no restriction on how you get out of bed, and nothing to protect while it unites, so ordinary activity resumes earlier even while the incision is still sore. Nerve pain along the rib settles over weeks to a few months for most people. A minority describe a lasting altered sensation or ache along that rib line. Local anesthetic blocks placed at the time of surgery and a proper pain plan for the first fortnight make a substantial difference, so ask what the unit uses. Any surgeon who calls this operation less painful without qualification is selling. One who explains the trade is describing it accurately.

Theater day and the first nights

Two to three hours covers a standard single-graft case, and the hours divide like this.

Two to three hours, divided

Aspirin starts immediately and continues indefinitely. Statin therapy, blood pressure control and stopping smoking do more for the years ahead than the operation itself, and a surgeon who says so is telling you the truth about coronary disease.

What can go wrong

Conversion to a sternotomy carries the specific risk of this approach, and it belongs in every consent conversation as a planned possibility. It happens when the target artery cannot be reached or exposed safely, when the heart does not tolerate being lifted or stabilized, or when bleeding needs control that a small incision cannot provide. Converting is the safe choice. Persisting through an exposure that has gone bad is the dangerous one.

Early graft failure undoes the operation, and flow measurement before closing exists to catch it. Bleeding needing a return to theater, wound infection at the rib incision, fluid or air collecting around the left lung, an irregular heart rhythm in the first days, and the general risks of any cardiac operation including stroke and kidney injury make up the rest. One number deserves asking for directly. What proportion of this unit's MIDCAB cases converted to sternotomy last year, and what proportion needed a return to theater.

Getting back to normal

The weeks have a shape, and the first one is the hardest for a reason that is easy to misread as something going wrong.

1. Through the first fortnight the rib incision dominates. Deep breaths and coughing hurt, and the breathing exercises the physiotherapist sets are the single most useful thing against a chest infection even though they are the least comfortable. Sleeping propped up helps.
2. From the second to the sixth week walking distance extends steadily.
3. Driving becomes possible once you can perform an emergency stop and turn to look behind without flinching, commonly in the third or fourth week, against the six to eight a divided sternum demands.
4. Desk work resumes somewhere between three and five weeks.

Cardiac rehabilitation, meaning a supervised exercise and education program, improves both survival and confidence, and it should be arranged near home before you travel. Two developments need contacting someone the same day. Chest pain resembling what took you to hospital in the first place, and a wound becoming hot, red and increasingly painful.

Planning the trip

Twelve to sixteen days in the country covers an uncomplicated single-graft case. Two or three days at the front go to reviewing the angiogram, blood tests, echocardiography, anesthetic assessment and the consultation itself, the admission accounts for four to six nights counting intensive care, and the remainder allows wound review, a repeat chest film and a fitness-to-fly assessment. Multivessel work through a small incision extends that to around three weeks.

Flying too early after cardiac surgery carries real risk, so the departure date belongs to the surgical team and not to the airline's change fee.

Three arrangements need making before you leave home.

1. A cardiologist near you who will take over the medication and the follow-up, since bypass surgery does not cure coronary disease and someone has to manage it for the rest of your life.
2. A cardiac rehabilitation place, which in many health systems takes weeks to arrange from a standing start.
3. Clarity about your blood thinners, meaning which ones stop before surgery, when each restarts, and what you take on the plane home.

What moves the price

Four things account for most of the variation between quotes. How many grafts are planned, since a single-graft MIDCAB and a four-graft minimally invasive case differ substantially in theater time. Whether the operation is done off the pump or with the heart-lung machine on standby, which changes the perfusion team and disposables involved. Then the intensive care nights the stay assumes. And whether stents form part of a hybrid plan, since those carry their own procedure and device costs and are frequently quoted separately by the cardiology department.

One question belongs with the surgeon rather than the accounts office. Ask whether the flow through the graft is measured before the chest is closed, because a single graft carrying the whole territory leaves no margin for a technical problem discovered later. Diabetes, kidney function, lung disease and earlier cardiac procedures all move the figure as well. A published package here ordinarily buys the surgeon and anesthesiologist, theater time, an agreed number of intensive care and ward nights, pre-operative imaging and bloods, and transfers with an interpreter, leaving flights, extra nights, treatment of a complication and any repeat procedure to be paid separately. Establish four things before accepting a quote. What happens financially if the operation converts to a sternotomy. The number of intensive care nights assumed, and the cost of each night beyond it. Whether any stents forming part of a hybrid plan sit inside the total or are billed separately by the cardiology department. And whether a repeat angiogram, if the team wants one before you fly, is covered. A surgeon who has reviewed your own angiogram can answer all of it, and that review costs nothing.

Back home, and the follow-up

Five documents leave the hospital with you.

• The operative note, naming which artery was grafted and with what.
• The graft flow measurement, if one was taken.
• The discharge summary listing every medication and its dose.
• A copy of the pre-operative angiogram.
• The echocardiogram report.

That medication list matters more than any other page, because coronary disease gets managed with drugs for life and a gap in the record becomes a gap in the treatment.

Once you are home, follow-up belongs to a cardiologist, starting with a review at four to six weeks and continuing at whatever interval that cardiologist sets, with attention paid at each visit to blood pressure, cholesterol, diabetes control and the unglamorous question of whether the medication is actually being taken rather than merely prescribed. That last one decides more outcomes than any of the others. Repeat angiography is arranged when symptoms suggest a problem, never on a fixed schedule.

Remote follow-up with the operating surgeon earns its keep through the first months, particularly for judging a wound that is slow to settle or rib pain that seems out of proportion, and a photograph or a scan sent to the team who did the surgery settles in a day what would otherwise cost a week of worry.

The graft lasts. The disease that made it necessary carries on, and the years after the operation belong to the tablets and the exercise more than to anything done in theater.

Frequently asked questions